| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA646034 | F | tested for cytotoxicity of HIV-1 replication in ATH-8 cells | Homo sapiens | 1 | ALA1130087 | cell-based format | Scientific Literature | |
| 2. | ALA645707 | F | Protection of ATH8 cells against the cytopathic effect of HIV. | 32 | ALA1123791 | cell-based format | Scientific Literature | ||
| 3. | ALA645708 | F | Required dose to reduce viability of normal uninfected ATH8 cells. | Homo sapiens | 32 | ALA1123791 | cell-based format | Scientific Literature | |
| 4. | ALA645709 | F | Antiviral activity against HIV-1 using CD4+ ATH8 cells at a concentration of 25 uM; No detectable activity | Homo sapiens | 2 | ALA1149937 | cell-based format | Scientific Literature | |
| 5. | ALA645710 | F | Antiviral activity against HIV-1 using CD4+ ATH8 cells at a concentration of 25 uM; moderately toxic | Homo sapiens | 1 | ALA1149937 | cell-based format | Scientific Literature | |
| 6. | ALA645711 | F | Antiviral activity against HIV-1 using CD4+ ATH8 cells at a concentration of 5 uM; No detectable activity | Homo sapiens | 3 | ALA1149937 | cell-based format | Scientific Literature | |
| 7. | ALA645712 | F | Compound was evaluated for the inhibition of replication and cytopathic effect of HIV-1 in ATH8 cells | Homo sapiens | 2 | ALA1129608 | cell-based format | Scientific Literature | |
| 8. | ALA645857 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 9. | ALA645858 | F | Inhibitory activity against HIV-1 in ATH8 cells | Homo sapiens | 1 | ALA1128724 | cell-based format | Scientific Literature | |
| 10. | ALA645859 | F | Inhibitory activity against HIV-1 in ATH8 cells; IA means Inactive | Homo sapiens | 1 | ALA1128724 | cell-based format | Scientific Literature | |
| 11. | ALA645860 | F | The compound was tested for anti HIV-activity (active) against ATH8 cell line | Homo sapiens | 3 | ALA1132532 | cell-based format | Scientific Literature | |
| 12. | ALA645861 | F | Compound was evaluated for the inhibition of replication and cytopathic effect of HIV-1 in ATH8 cells | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 13. | ALA645862 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells | Homo sapiens | 3 | ALA1129608 | cell-based format | Scientific Literature | |
| 14. | ALA645863 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells 10(uM) | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 15. | ALA645864 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells at | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 16. | ALA645865 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells at 0.05 (uM) | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 17. | ALA645866 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells at 0.05(uM) | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 18. | ALA645867 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells at 0.1(uM) | Homo sapiens | 3 | ALA1129608 | cell-based format | Scientific Literature | |
| 19. | ALA645868 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells at 0.5 (uM) | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature | |
| 20. | ALA645869 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells at 0.5(uM) | Homo sapiens | 1 | ALA1129608 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!